FUNCTIONAL HEALTH GUIDE -- CHRONIC KIDNEY DISEASE IN CATS

Functional Health — Chronic Kidney Disease (CKD) in Cats

A Longevity-Focused, Functional Approach
By Dr. Kevin Toman, The Longevity Vet

WANT THIS AS A DOWNLOADABLE PDF?  Here You Go.


Why CKD Deserves a Different Conversation

Chronic kidney disease (CKD) is the most common chronic disease of aging cats—and one of the most misunderstood.

What matters most is not simply whether a cat has CKD, but:

  • how early it is detected

  • how inflammation, blood pressure, protein loss, and nutrition are managed

  • how biomarkers are tracked over time

CKD is progressive — but the slope of progression is highly modifiable.

This worksheet is a decision-support tool, not a diagnosis.
It is organized around The 3 Core Goals.


The 3 Core Goals

This worksheet is designed to help you:

  1. Clarify what matters most right now

  2. Determine the next best test (if any)

  3. Choose the most appropriate next step


Core Goal 1: Clarify What Matters Most Right Now

Frequency, Impact, and Prognosis

  • ~30% of cats over age 10 show evidence of CKD

  • 50–80% of cats over age 15 are affected

  • Many cats with early-stage CKD live years longer than expected with thoughtful care

Early detection and functional management consistently outperform late, crisis-based intervention.


IRIS Staging: The Framework That Guides Strategy

Stage 1

  • Normal creatinine; abnormal urine concentration, SDMA, or protein

  • Greatest opportunity for longevity gains

Stage 2

  • Mild azotemia, often asymptomatic

  • Ideal stage for anti-inflammatory and renal-protective strategies

Stage 3

  • Moderate renal insufficiency with clinical signs

  • Goal: slow decline, preserve appetite, maintain hydration and weight

Stage 4

  • Advanced renal failure

  • Goal: comfort, symptom relief, and quality of life

Functional Health focuses on trajectory, not just stage.


Core Goal 2: Determine the Next Best Test 

Functional Biomarkers: Seeing CKD Early

Traditional bloodwork detects CKD late. Functional Health focuses on renal reserve and trend detection.

Core biomarkers

  • Urine Specific Gravity (USG): earliest marker of concentrating loss

  • Urine protein (UPC or dipstick): predictor of progression

  • SDMA: rises with ~25–40% nephron loss

  • Cystatin-C: emerging early GFR marker

  • Creatinine / BUN: late indicators

Urine testing in cats is not optional. It is foundational.


How Early Can CKD Be Detected?

Test Approx. Kidney Function Lost Meaning
Urine Specific Gravity 20–30% Earliest warning
Proteinuria (UPC) ~30% Accelerates damage
SDMA 25–40% Early blood marker
Cystatin-C 30–40% Early GFR decline
Creatinine 65–75% Late diagnosis
BUN 70–75% Late, nonspecific

Mandatory Risk Factors & Rule-Outs

Every cat with suspected or confirmed CKD must be evaluated for:

Hypertension

  • Common, silent, destructive

  • Accelerates renal decline

  • Requires proper feline measurement technique

Heart Disease (especially HCM)

  • Cardiac output directly affects renal perfusion

  • CKD promotes hypertension and cardiac remodeling

Dental Disease

  • Chronic oral inflammation increases systemic inflammatory burden

  • Proven contributor to CKD progression

Hyperthyroidism

  • Masks CKD by increasing GFR

  • Treatment often reveals underlying kidney disease

  • Must be addressed concurrently


The Heart–Kidney Axis: Why Cats Are Unique

The heart and kidneys function as a linked system.

  • Reduced cardiac output worsens renal perfusion

  • CKD increases blood pressure and cardiac workload

  • Management decisions must balance both organs simultaneously

Medication Interactions That Matter

  • Furosemide: lifesaving for heart failure, increases dehydration risk

  • ACE inhibitors / ARBs: reduce proteinuria and hypertension but require monitoring

Serial assessment of:

  • blood pressure

  • renal biomarkers

  • hydration status

is mandatory.


Core Goal 3: Choose the Most Appropriate Next Step

Supplements: Targeting Inflammation & Fibrosis

Functional CKD care prioritizes anti-inflammatory and anti-fibrotic strategies.

Fish Oil (Omega-3 Fatty Acids)Foundational

  • reduces renal inflammation

  • slows glomerular fibrosis

  • supports cardiovascular health

  • may reduce proteinuria

Use high-quality, purified marine sources at cat-appropriate doses.

Additional support (biomarker-guided)

  • antioxidants / anti-inflammatory compounds

  • phosphorus binders when indicated

  • appetite, hydration, and gut-support tools as disease advances

Supplements should be strategic, not generic.


Prescription Medications: Protecting Remaining Function

ACE Inhibitors / ARBs
Indicated for:

  • proteinuria

  • hypertension

  • glomerular protection

Benefits:

  • reduce intraglomerular pressure

  • slow progression

  • improve long-term outcomes

Monitoring is essential.


Rapamycin: A Longevity-Focused Therapy (Emerging)

Rapamycin is a potent anti-inflammatory and anti-fibrotic agent with proven longevity benefits across mammalian species.

In cats, it may:

  • reduce systemic inflammation

  • protect renal microvasculature

  • benefit concurrent cardiac disease (especially HCM)

Rapamycin is currently under study at two U.S. veterinary schools for feline kidney and heart disease.
It is not yet standard of care, but represents a next-generation longevity option when used thoughtfully and with monitoring.


Dietary Therapy: Modern Thinking for Aging Cats

What we no longer recommend

  • severe protein restriction

  • weight loss in senior cats

  • chasing lab numbers at the expense of body condition

What we aim for instead

  • adequate, high-biologic-value protein

  • weight and muscle maintenance

  • moderate phosphorus control

  • high moisture intake

  • excellent palatability

Protein quality matters more than quantity.

Approximate biologic value:
Fish > Poultry > Eggs > Red meat

A cat that maintains weight and appetite lives longer.


One-Page Early Detection & Action Pathway

Cat ≥7 years (or any age with risk factors)

  1. Urinalysis

    • USG ≥1.035 → monitor annually

    • USG <1.035 → proceed

  2. Urine Protein

    • negative → continue evaluation

    • positive → UPC + blood pressure

  3. Blood Biomarkers

    • SDMA ± cystatin-C

    • BUN/creatinine baseline

  4. Mandatory Rule-Outs

    • blood pressure

    • total T4

    • cardiac assessment

    • dental exam

  5. Stage (IRIS) + Functional Plan

    • diet optimization

    • fish oil first-line

    • ACE inhibitor if proteinuric or hypertensive

    • biomarker tracking every 3–6 months


Prognosis & Longevity

CKD is not a death sentence.

  • Early-detected cats often live many additional high-quality years

  • Progression can be slowed dramatically

  • Quality of life is usually excellent with proper management

The most important variable is how early CKD is recognized and how thoughtfully it is managed over time.


When to Escalate Beyond the Worksheet

A PET LONGEVITY CONSULT  is appropriate when:

  • multiple systems are involved (kidney + heart + blood pressure)

  • proteinuria or hypertension is present

  • medication decisions feel complex

  • you want a long-term, prioritized plan


Start a Pet Longevity Consult


Your Next Step

For most cat parents:

  • begin with Functional Health — Foundations to establish baseline risk

  • layer in CKD-specific monitoring early

  • escalate thoughtfully before crisis points

There is no single correct intervention — only the appropriate next step for your cat today.


About These Worksheets


This worksheet is part of the Functional Health system developed at PetFunctionHealth.com, designed to identify early decline and guide long-term longevity strategy.


Final Message to Cat Parents

Cats are quiet sufferers and brilliant compensators.
Functional medicine allows us to listen before the crisis, intervene before damage is advanced, and protect what matters most:

Time, Comfort, and Dignity.